Lu Yudie, Liang Zhiyu, Feng Jie, Huang Lin, Guo Shuai, Yi Peiwei, Xiong Wei, Chen Sijin, Yang Sugeun, Xu Yikai, Li Yan, Chen Xiaoyuan, Shen Zheyu
School of Biomedical Engineering, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Adv Sci (Weinh). 2022 Nov 15;10(1):e2205109. doi: 10.1002/advs.202205109.
To surmount the major concerns of commercial small molecule Gd chelates and reported Gd-based contrast agents (GBCAs) for magnetic resonance imaging (MRI), a new concept of organogadolinium macrochelates (OGMCs) constructed from the coordination between Gd and macromolecules is proposed. A library of macromolecules were screened for Gd coordination, and two candidates [i.e., poly(acrylic acid) (PAA), and poly(aspartic acid) (PASP)] succeeded in OGMC formation. Under optimized synthesis conditions, both Gd-PAA12 and Gd-PASP11 OGMCs are outstanding T -weighted CAs owing to their super high r values (> 50 mm s , 3.0 T) and ultralow r /r ratios (< 1.6, 3.0 T). The ferromagnetism of OGMCs is completely different from the paramagnetism of commercial and reported GBCAs. The ferromagnetism is very weak (M < 1.0 emu g ) leading to a low r , which is preferred for T MRI. Gd is not released from the OGMC Gd-PAA12 and Gd-PASP11, ensuring biosafety for in vivo applications. The safety and T -weighted MRI efficiencies of the OGMC Gd-PAA12 and Gd-PASP11 are tested in cells and mice. The synthesis method of the OGMCs is facile and easy to be scaled up. Consequently, the OGMC Gd-PAA12 and Gd-PASP11 are superior T -weighted CAs with promising translatability to replace the commercial Gd chelates.
为克服商业小分子钆螯合物以及已报道的用于磁共振成像(MRI)的钆基造影剂(GBCAs)的主要问题,提出了一种由钆与大分子配位构建的有机钆大螯合物(OGMCs)的新概念。筛选了一系列大分子用于钆配位,两种候选物[即聚丙烯酸(PAA)和聚天冬氨酸(PASP)]成功形成了OGMCs。在优化的合成条件下,Gd-PAA12和Gd-PASP11这两种OGMCs都是出色的T加权造影剂,因为它们具有超高的r值(>50 mM-1 s-1,3.0 T)和超低的r2/r1比值(<1.6,3.0 T)。OGMCs的铁磁性与商业和已报道的GBCAs的顺磁性完全不同。其铁磁性非常弱(M<1.0 emu g-1),导致r2较低,这对于T2加权MRI是有利的。钆不会从OGMC Gd-PAA12和Gd-PASP11中释放出来,确保了体内应用的生物安全性。在细胞和小鼠中测试了OGMC Gd-PAA12和Gd-PASP11的安全性和T2加权MRI效率。OGMCs的合成方法简便且易于放大。因此,OGMC Gd-PAA12和Gd-PASP11是具有优异T2加权性能且有望实现转化以替代商业钆螯合物的造影剂。